Business Wire

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, today announced that it has ...
MM&M

Flagship’s Generate:Biomedicines closes $273M Series C funding round

Generate:Biomedicines, a clinical-stage biotherapeutics company backed by life sciences venture capital company Flagship Pioneering, announced Thursday morning that it closed a $273 million Series C ...
Business Wire

Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion ...
FierceBiotech

Generate raises $273M—$100M less than previous round—but a huge bounty

Flagship Pioneering-founded Generate Biomedicines is tacking on a gigantic $273 million in series C funds, though the haul didn't reach the heights of the biotech’s previous $370 million raise back in ...